Clinical Trials
- Heart/Cardiovascular
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists (PROMPT-MRA)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Heart/Cardiovascular
CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM (SEQUOIA-HCM)
- Ages18 years - 85 years
- GenderBoth
Mechanisms of Diuretic Resistance in Heart Failure (MsDR)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Endocrine System
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations (SCAN-MP)
- Ages60 years and older
- GenderBoth
- Heart/Cardiovascular
Ertugliflozin in Acute Heart Failure
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Critical Care Cardiology Trials Network (CCCTN) Registry
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA)
- Ages45 years and older
- GenderBoth